Clinical Trials Directory

Trials / Completed

CompletedNCT02318758

Pharmacokinetic Interaction of Oral Treprostinil and Ethanol in Healthy Volunteers

Randomized, Single Dose, 4-Way Cross-over Study to Investigate the Pharmacokinetic Interaction of Oral Treprostinil and Ethanol in Healthy Volunteers

Status
Completed
Phase
Phase 1
Study type
Interventional
Enrollment
32 (actual)
Sponsor
United Therapeutics · Industry
Sex
All
Age
21 Years – 55 Years
Healthy volunteers
Accepted

Summary

A study to assess the interaction of acohol and oral treprostinil.

Detailed description

This study will compare the effects of ethanol on the PKs of a 1 mg dose of UT-15C in healthy volunteers to determine the in vivo effects of ethanol, including the timing of ethanol consumption in relation to UT-15C ingestion. This is an open-label, randomized, single-center, four-way (period), crossover study in which 28 healthy volunteers will receive a single 1 mg oral dose of UT-15C and/or ethanol. Eligible subjects will be randomly assigned to one of four treatment sequences such that all subjects will receive all four sequences in a pre-specified order.

Conditions

Interventions

TypeNameDescription
DRUGUT-15Csustained release oral treprostinil
OTHERethanolAbsolut 100 vodka

Timeline

Start date
2014-09-01
Primary completion
2014-10-01
Completion
2014-12-01
First posted
2014-12-17
Last updated
2015-03-24

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT02318758. Inclusion in this directory is not an endorsement.